According to an article in the Rochester, Minn. Post-Bulletin, the Minnesota Partnership for Biotechnology and Medical Genomics has just announced that it will award nearly $6 million to seven teams doing research on heart disease, mesothelioma, infection prevention and epilepsy.
The partnership is a collaboration of the University of Minnesota, Mayo Clinic and the state of Minnesota and also includes money earmarked for projects dealing with nanotech medical sensors and human-safe pesticides designed specifically for use in the state of Minnesota.
“These new awards reflect the Partnership’s continuing focus on major diseases affecting Minnesotans, and break new ground with innovative biotech ideas that can have a major impact on a range of health issues,” said Dr. Mark Paller, partnership program director at the University of Minnesota.
Mesothelioma has been a growing concern in Minnesota, and has greatly affected the health of those who work or have worked in the taconite mines in the state’s Iron Range. Studies done in that region indicate that the area has a much higher rate of mesothelioma than anywhere else in the state.
The funding will be for two years and the partnership hopes that by the end of that time period, they can attract other federal or private sources that might want to contribute to research for these diseases.